No Data
No Data
Benchmark Co. Maintains Milestone Scientific(MLSS.US) With Buy Rating, Maintains Target Price $1.25
Analysts Offer Insights on Healthcare Companies: Milestone Scientific (MLSS), Neurocrine (NBIX) and Argenx Se (ARGX)
Milestone Scientific FY 2024 GAAP EPS $(0.06) Misses $(0.05) Estimate, Sales $8.630M Miss $9.261M Estimate
Express News | Milestone Scientific Reports Year-End 2024 Financial Results and Reports Strong Outlook for 2025
Press Release: Milestone Scientific Reports Year-End 2024 Financial Results and Reports Strong Outlook for 2025
Milestone Scientific | 10-K: FY2024 Annual Report